Published: 2017-03-28

An unusual presentation of hemoglobin SD Punjab in a Saudi Arabian adult

Soheir S. Adam, Ahmed N. Sahly, Ahmed A. Jamjoom, Abdulrahman H. Ghoneim, Thunayyan M. Almasoudi, Mohammed O. Mohsen, Maha A. Badawi


HbDPunjab is an uncommon variant hemoglobin that does not result in significant pathology when inherited as a homozygous disorder. When inherited with other hemoglobinopathies, it may result in varying disease phenotypes. HbSDPunjab has been rarely reported in Saudi Arabia, coexisting with alpha or beta thalassemia. In this report, we discuss the case of a 39 years old male who presented with severe anemia and renal injury and was later diagnosed with HbSDPunjab through electropheresis and genetic testing.


Hemoglobin D, Sickle cell anemia

Full Text:



Alotaibi ST, Ahmed MA. Hemoglobin D trait with alpha thalassemia in a Saudi family. Ann Saudi Med. 2000;20(3-4):251-2.

Owaidah TM, Al-Saleh MM, Al-Hellani AM. Hemoglobin D/beta-thalassemia and beta-thalassemia major in a Saudi family. Saudi Med J. 2005;26(4):674-7.

Schnee J, Aulehla-Scholz C, Eigel A, Horst J. Hb D Los Angeles (D-Punjab) and Hb Presbyterian: analysis of the defect at the DNA level. Human Genetics. 1990;84(4):365-7.

Itano HA. A Third abnormal hemoglobin associated with hereditary hemolytic anemia. Proc Natl Acad Sci U S A. 1951;37(12):775-84.

Yavarian M, Karimi M, Paran F, Neven C, Harteveld CL, Giordano PC. Multi centric origin of Hb D-Punjab [beta121(GH4)Glu-->Gln, GAA>CAA]. Hemoglobin. 2009;33(6):399-405.

Rahbar S. Haemoglobin D Iran: 2 22 glutamic acid leads to glutamine (B4). Br J Haematol. 1973;24(1):31-5.

Rohe RA, Sharma V, Ranney HM. Hemoglobin D Iran alpha A2 beta 22 2-Glu leads to Gln in association with thalassemia. Blood. 1973;42(3):455-62.

Sturgeon P, Itano HA, Bergren WR. Clinical manifestations of inherited abnormal hemoglobins. I. The interaction of hemoglobin-S with hemoglobin-D. Blood. 1955;10(5):389-404.

Adachi K, Kim J, Ballas S, Surrey S, Asakura T. Facilitation of Hb S polymerization by the substitution of Glu for Gln at beta 121. J Biol Chem. 1988;263(12):5607-10.

Kelleher JF Jr., Park JO, Kim HC, Schroeder WA. Life-threatening complications in a child with hemoglobin SD-Los Angeles disease. Hemoglobin. 1984;8(3):203-13.

Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet. 2010;376(9757):2018-31.

Inati A, Koussa S, Taher A, Perrine S. Sickle cell disease: new insights into pathophysiology and treatment. Pediatr Ann. 2008;37(5):311-21.

Brousse V, Makani J, Rees DC. Management of sickle cell disease in the community. BMJ. 2014;348:g1765.

Mekontso Dessap A, Contou D, Dandine-Roulland C. Environmental influences on daily emergency admissions in sickle-cell disease patients. Medicine (Baltimore). 2014;93(29):e280.

Marmot M. Social determinants of health inequalities. Lancet. 2005;365(9464):1099-104.

Halphen I, Elie C, Brousse V. Severe nocturnal and postexercise hypoxia in children and adolescents with sickle cell disease. PloS one. 2014;9(5):e97462.

Faes C, Balayssac-Siransy E, Connes P. Moderate endurance exercise in patients with sickle cell anaemia: effects on oxidative stress and endothelial activation. Br J Haematol. 2014;164(1):124-30.

Guasch A, Navarrete J, Nass K, Zayas CF. Glomerular involvement in adults with sickle cell hemoglobinopathies: Prevalence and clinical correlates of progressive renal failure. J Am Soc Nephrol. 2006;17(8):2228-35.

Lumerman JH, Hom D, Eiley D, Smith AD. Heightened suspicion and rapid evaluation with CT for early diagnosis of partial renal infarction. J Endourol. 1999;13(3):209-14.

Allon M. Renal abnormalities in sickle cell disease. Arch Intern Med. 1990;150(3):501-4.

Sklar AH, Perez JC, Harp RJ, Caruana RJ. Acute renal failure in sickle cell anemia. Int J Artif Organs. 1990;13(6):347-51.

Audard V, Homs S, Habibi A. Acute kidney injury in sickle patients with painful crisis or acute chest syndrome and its relation to pulmonary hypertension. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association- European Renal Association. 2010;25(8):2524-9.

Falk RJ, Scheinman J, Phillips G, Orringer E, Johnson A, Jennette JC. Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme. New England J Med. 1992;326(14):910-5.

Bhathena DB, Sondheimer JH. The glomerulopathy of homozygous sickle hemoglobin (SS) disease: morphology and pathogenesis. Journal of the American Society of Nephrology: JASN. 1991;1(11):1241-52.

Nasr SH, Markowitz GS, Sentman RL, D'Agati VD. Sickle cell disease, nephrotic syndrome, and renal failure. Kidney Int. 2006;69(7):1276-80.

Bruno D, Wigfall DR, Zimmerman SA, Rosoff PM, Wiener JS. Genitourinary complications of sickle cell disease. J Urol. 2001;166(3):803-11.

Hatch FE, Crowe LR, Miles DE, Young JP, Portner ME. Altered vascular reactivity in sickle hemoglobinopathy. A possible protective factor from hypertension. Am J Hypertens. 1989;2(1):2-8.

Oberoi SS, Marya CM, Sharma N, Mohanty V, Marwah M, Oberoi A. Knowledge and attitude of Indian clinical dental students towards the dental treatment of patients with human immunodeficiency virus (HIV)/acquired immune-deficiency syndrome (AIDS). Int Dent J. 2014;64(6):324-32.

Patel S, Purohit P, Mashon RS. The effect of hydroxyurea on compound heterozygotes for sickle cell-hemoglobin D-Punjab--a single centre experience in eastern India. Pediatr Blood Cancer. 2014;61(8):1341-6.

El-Kalla S, Mathews AR. Hb D-Punjab in the United Arab Emirates. Hemoglobin. 1997;21(4):369-75.